Immunotherapy Archives - Baylor College of Medicine Blog Network

This novel immunotherapy may help the immune system recognize and attack cancer cells in a way that other immunotherapies have not been able to do thus far.

From The Labs

Baylor College of Medicine resident co-authors groundbreaking cancer paper in Nature

November 25, 2025 Baylor resident, cancer survival, COVID-19 mRNA vaccine, Dermatology, immune checkpoint inhibitors, Immunotherapy, lung cancer, melanoma, Research

From the Labs sat with Dr. Rishabh Lohray, a first-year dermatology resident, to learn about his experiences as a member of the research team and a little about him.

Dr. R. Taylor Ripley and William Donchig.

The Stitch

A new treatment path for mesothelioma: Join the Baylor clinical trial

September 3, 2025 Cancer, Chemotherapy, Immunotherapy, Mesothelioma, resectable mesothelioma

Learn more about a new clinical trial aimed at improving outcomes for patients with resectable mesothelioma.

From The Labs

A potential new therapeutic target for Group 3 medulloblastoma

August 8, 2024 CAR T cell, grade3-medulloblastoma, Immunotherapy, pediatric brain cancer, protogenin, Research

Researchers identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma in the developing brain.

From The Labs

Study of spliceosome-targeting cancer therapies reveals an overlooked role of mis-spliced RNAs themselves

January 19, 2021 apoptosis, cancer treatment, Immunotherapy, Research, RNA splicing, Spliceosome-targeting therapies, triple-negative breast cancer

Endogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.

From The Labs

CAR NKT cells, a promising step forward in the treatment of solid tumors

November 10, 2020 CAR NK T cells, clinical trial, Immunotherapy, neuroblastoma, Research, solid tumors

An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.

From The Labs

New insights into the mediators of patient recovery after CAR T cell immunotherapy

July 21, 2020 cancer therapy, CAR T cell, Clinical Trials, complete response, HER-2, Immunotherapy, Research, rhabdomyosarcoma

Clinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.

Momentum

Immunotherapy improves quality of life for mesothelioma patient

November 19, 2019 Cancer, Dan L Duncan Comprehensive Cancer Center, Healthcare, Immunotherapy, Mesothelioma, Molly Chiu

When Samir Tanios was diagnosed with malignant pleural mesothelioma in September 2018, he was in poor condition. He couldn’t take a deep breath or walk